Cannabis stocks surge on rescheduling news; Aurora Cannabis jumps 16% despite no US strategy. Read why I'm maintaining my ...

Aurora Cannabis posted mixed Q1 FY2026 results, facing sales pressure, covenant issues, and looming German regulatory risks.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Shares of Aurora Cannabis Inc. ACB shed 2.53% to $5.39 Thursday, on what proved to be an all-around poor trading session for ...

Greetings and welcome to Aurora Cannabis Incorporated Fiscal First Quarter 2026 Results Conference Call all participants will ...

Aurora Cannabis Inc. (NASDAQ:ACB), a prominent Canadian medical cannabis company, is strengthening its global footprint by ...

Aurora Cannabis (ACB) delivered earnings and revenue surprises of -205.56% and +6.50%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

ACB EDMONTON, AB, Aug. 8, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a ...

If you invested in Canadian cannabis stocks just after legalization in 2018, at the height of investor fervor, you are likely ...

Potency Cultivars, Expanding Patient Choice in Australia EDMONTON, ALBERTA, Aug. 12, 2025 /CNW/ – Aurora Cannabis Inc. (NASDAQ: ACB) ...

U.S. President Donald Trump’s administration is looking to reclassify marijuana as a less dangerous drug, a shift that could ...